Viewing StudyNCT01222780



Ignite Creation Date: 2024-05-05 @ 10:59 PM
Last Modification Date: 2024-10-26 @ 10:26 AM
Study NCT ID: NCT01222780
Status: COMPLETED
Last Update Posted: 2020-01-18
First Post: 2010-10-15

Brief Title: To Evaluate the Safety Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Sponsor: Acrotech Biopharma Inc
Organization: Acrotech Biopharma Inc

Organization Data

Organization: Acrotech Biopharma Inc
Class: INDUSTRY
Study ID: 100220
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Acrotech Biopharma Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH